China SXT Pharmaceuticals, Inc. Financing Cash Flow
China SXT Pharmaceuticals, Inc. (SXTC) reported Financing Cash Flow of $14.43 million for the 12-month period ending 2026-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-01
| Period end | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|
| 2026-03-31 | $14.43M 20-F · filed 2026-07-01 | |
| 2025-09-30 | $5.37M 6-K · filed 2025-12-31 | |
| 2025-03-31 | $8.40M 20-F · filed 2026-07-01 | |
| 2024-09-30 | $7.24M 6-K · filed 2025-12-31 | |
| 2024-03-31 | -$2.62M 20-F · filed 2026-07-01 | |
| 2023-09-30 | -$4.46M 6-K · filed 2025-03-28 | |
| 2023-03-31 | $2.94M 20-F · filed 2025-07-31 | |
| 2022-09-30 | -$11.07M 6-K · filed 2024-04-05 | |
| 2022-03-31 | $1.60M 20-F · filed 2024-08-13 | |
| 2021-09-30 | -$3.91M 6-K · filed 2023-02-24 | |
| 2021-03-31 | $12.41M 20-F · filed 2023-07-31 | |
| 2020-09-30 | $274.50K 6-K · filed 2022-01-14 | |
| 2020-03-31 | $3.02M 20-F/A · filed 2023-05-19 | |
| 2019-09-30 | $6.91M 6-K · filed 2021-01-28 | |
| 2019-03-31 | $9.04M 20-F · filed 2021-08-13 | |
| 2018-09-30 | $341.48K 6-K/A · filed 2020-05-22 | |
| 2018-03-31 | -$314.22K 20-F · filed 2020-07-31 | |
| 2017-03-31 | -$50.56K 20-F · filed 2019-08-15 |